Teiko to present two posters at the 2024 SITC annual meeting

Teiko is excited to announce that two posters have been accepted for presentation at the 2024 Society for Immunotherapy of Cancer (SITC) annual meeting in Houston from November 8 – 10th. 

Teiko will present its work on optimizing fixed whole blood samples for mass cytometry, highlighting the development and validation of the TokuKit, a two-step collection kit that stabilizes whole blood for long-term storage at -80°C for up to 24 months. The poster will show inter- and intra-run validation for a 41+ marker pan-immunophenotyping panel and performance comparisons to fresh blood, supporting the use of the TokuKit in clinical trials for biomarker research and immune monitoring.

In addition, Teiko will also highlight its research on addressing the challenge of processing fresh blood for flow cytometry in clinical trials by optimizing the TokuKit fixation method for high-dimensional immune profiling using a 20+-marker spectral flow cytometry panel, which shows comparable (r=0.975) results to freshly processed samples.

Poster Presentation Details:

Abstract Title: It’s about time: Rapid on-site fixation of whole blood samples prior to high-dimensional flow cytometric analysis

Abstract Number: 57

Presenter: Kristina Magee, MD-PhD, Associate Director Lab Operations

Poster Presentation Date: Friday, Nov. 8